Immunoregulation and tolerance

Transplantation Proceedings

Volumn 42, Issue 9 SUPPL., 2010, Pages

  Knechtle, S J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ACUTE GRAFT REJECTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE ACTIVATION; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; GENOTYPE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIVER TRANSPLANTATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T CELL DEPLETION;

EID: 78649411375     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.039     Document Type: Article

References (13)

1. N. Pilat, U. Baranyi, and C. Klaus Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning Am J Transplant 2010 Feb 10 (Epub ahead of print)
2. K.E. Webster, S. Walters, and R.E. Kohler In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression J Exp Med 206 2009 751
3. W. Gao, Y. Lu, and B. El Essawy Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells Am J Transplant 7 2007 1722
4. K.A. Newell, A. Asare, and A.D. Kirk Identification of a B cell signature associated with renal transplant tolerance in humans J Clin Invest 120 2010 1836
5. ClinicalTrials.gov : Effect of rapamycin on tolerance-related biomarkers on stable liver transplant recipients. Available at http://clinicaltrials.gov/ ct2/show/NCT01034345. Accessed September 23, 2010
6. M. Martnez-Llordella, J.J. Lozano, and I. Puig-Pey Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients J Clin Invest 118 2008 2845
7. S.J. Knechtle, J. Pascual, and D.D. Bloom Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring Am J Transplant 9 2009 1087
8. D. Bloom, Z. Chang, and K. Pauly BAFF is increased in renal transplant patients following treatment with alemtuzumab Am J Transplant 9 2009 1835
9. S.S. Kelishadi, A.M. Azimzadeh, and T. Zhang Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys J Clin Invest 120 2010 1275
10. S.J. Knechtle, J. Kwun, and N. Iwakoshi Prevention trumps treatment of antibody-mediated transplant rejection J Clin Invest 120 2010 1036
11. S. Qian, L. Lu, and F. Fu Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction J Immunol 158 1997 4654
12. I.N. Crispe The liver as a lymphoid organ Annu Rev Immunol 27 2009 147
13. A.J. Demetris, J.G. Lunz, and P. Randhawa Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective Transplant Int 22 2008 120